Medication Development in Alcoholism: Investigating PPAR Agonists

计划入组 50 人 · 首次发布于 2014 年 6 月 6 日

PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease

计划入组 143 人 · 首次发布于 2007 年 11 月 7 日

Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)

计划入组 88 人 · 首次发布于 2015 年 1 月 15 日

PPAR agonists (High Point)

MBX-213

CDE-001

Crinetics

United States

Pear Therapeutics, Inc.

United States

Par Pharmaceutical, Inc.

United States

New PPAR Agonists Expand Treatment Landscape for Primary Biliary Cholangitis

PPAR-gamma Pathway Modulation Enhances NECTIN4-Targeted CAR-T Therapy for Bladder Cancer

Inventiva's Lanifibranor Shows Promise in Reversing Liver Vascular Damage in MASH Patients